CLI Announces New Senior Fellow and Director of Life Sciences
Today, the Charlotte Lozier Institute (CLI), the education and research arm of national pro-life group Susan B. Anthony List (SBA List), announced that associate scholar Tara Sander Lee, Ph.D. will transition to a larger role as CLI’s Senior Fellow and Director of Life Sciences.
CLI president Charles A. “Chuck” Donovan, said:
“During her time as a CLI associate scholar, Dr. Tara Sander Lee has made an impact on promoting ethical advancements in healthcare especially for the unborn, and we look forward to her contributions as Senior Fellow and Director of Life Sciences. In her increased capacity, Dr. Sander Lee’s work will broadly encompass research, analysis and communication on the science associated with human life.”
Commenting on her new role at CLI, Dr. Sander Lee said,
“I look forward to continued collaboration with the talented team of scholars and professionals at CLI in using the best scientific research and data to protect human life. I’m excited about the opportunity to expand my research and play a greater role in the conversation around life sciences and policies that advance human life.”
In her new position with CLI, Dr. Sander Lee’s work will encompass genetics, cell biology and the physiology of normal and abnormal human development with an emphasis on prenatal and early postnatal periods; potential medical interventions in utero; stem cell, fetal tissue and genetic research; surgical and chemical abortion; pharmaceuticals that may act on reproduction and human development, as well as other related areas of science, medicine and technology.
Dr. Sander Lee is a scientist with nearly 20 years’ experience in academic and clinical medicine. Dr. Sander Lee completed her undergraduate studies at Beloit College and received a Ph.D. in biochemistry from the Medical College of Wisconsin (MCW). She then completed her research fellowship training at Harvard Medical School and Boston Children’s Hospital, before returning to MCW as a faculty member. At MCW, she established a research lab and served as the first scientific director of molecular diagnostics at Children’s Hospital of Wisconsin with an emphasis on the genetic cause of childhood disease.